Abbott Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

24.05.23	European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations (PR Newswire)
20.05.23	Abbott Unveils Late-Breaking Data Showing the World's First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints (PR Newswire)
19.05.23	Abbott Announces FDA Approval For TactiFlex Ablation Catheter (RTTNews)
19.05.23	Abbott Receives FDA Approval for TactiFlex™ Ablation Catheter for Treatment of Abnormal Heart Rhythm (PR Newswire)
18.05.23	Abbott Laboratories Says FDA Approves Assert-IQ Insertable Cardiac Monitor (RTTNews)
18.05.23	Abbott Receives FDA Clearance for Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term (PR Newswire)
16.05.23	Abbott Says FDA Approves Spinal Cord Stimulation Devices To Treat Chronic Back Pain (RTTNews)
16.05.23	Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options (PR Newswire)
11.05.23	Abbott Announces New Partnerships and Programs to Advance its Diversity in Clinical Trials Initiative (PR Newswire)
27.04.23	Abbott Completes Acquisition of Cardiovascular Systems, Inc. (PR Newswire)
25.04.23	Cytek Biosciences Set to Join S&P SmallCap 600 (PR Newswire)
25.04.23	Abbott Announces Two New FDA Clearances For Life Support System (RTTNews)
25.04.23	Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients (PR Newswire)
20.04.23	Abbott and New Global Consortium Partnership Address Viral Outbreaks Caused by Climate Change (PR Newswire)
19.04.23	Abbott Laboratories Q1 Profit Decreases, but beats estimates (RTTNews)
19.04.23	Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business (PR Newswire)
17.04.23	Abbott's FreeStyle Libre® Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries (PR Newswire)
14.04.23	Abbott: FDA Clears Reader For FreeStyle Libre 3 Integrated Continuous Glucose Monitoring System (RTTNews)
14.04.23	FDA Clears Reader for Abbott's FreeStyle Libre® 3 System (PR Newswire)
29.03.23	Abbott Hosts Conference Call for First-Quarter Earnings (PR Newswire)
23.03.23	Don't Mess with Your 'Melon': Abbott and the Brain Injury Association of America Urge 'If You Hit Your Head, Get it Checked' in New Public Service Announcement (PR Newswire)
07.03.23	Abbott Receives FDA Clearance for First Commercially Available Lab-based Blood Test to Help Evaluate Concussion (PR Newswire)
06.03.23	Abbott: FDA Clears FreeStyle Libre 2, 3 Sensors For Integration With AID Systems (RTTNews)
06.03.23	U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems (PR Newswire)
06.03.23	Abbott: Data Show Long-Term Benefits Of MitraClip Device For Treating Secondary Mitral Regurgitation (RTTNews)
05.03.23	Late-Breaking Data from Landmark COAPT™ Trial Show Long-Term Benefits of Abbott's MitraClip™ Device (PR Newswire)
04.03.23	New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation (PR Newswire)
28.02.23	Late-Breaking Data Reinforce Benefits of Abbott's Minimally Invasive Heart Devices (PR Newswire)
17.02.23	Abbott Declares 397th Consecutive Quarterly Dividend (PR Newswire)
09.02.23	Abbott To Acquire Cardiovascular Systems In $890 Mln Deal (RTTNews)
09.02.23	Abbott to Acquire Cardiovascular Systems, Inc. (PR Newswire)
26.01.23	Abbott Says FDA Oks Proclaim XR Spinal Cord Stimulation System To Treat DPN (RTTNews)
26.01.23	FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy (PR Newswire)
25.01.23	Abbott Issues FY23 Earnings, Sales Growth View - Update (RTTNews)
25.01.23	Abbott Laboratories Q4 Profit Decreases, but beats estimates (RTTNews)
25.01.23	Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook (PR Newswire)
21.01.23	Abbott Reportedly Under Criminal Probe Over Baby Formula (RTTNews)
17.01.23	Abbott Says FDA Oks Navitor TAVI System To Treat Severe Aortic Stenosis (RTTNews)
17.01.23	Abbott Receives FDA Approval for Navitor™, a Next-Generation TAVI System Designed to Treat Aortic Stenosis (PR Newswire)
07.01.23	Abbott, Blood Centers of America Launch First-of-its-Kind Mixed Reality Experience for Use During Blood Donation (PR Newswire)
04.01.23	Abbott Hosts Conference Call for Fourth-Quarter Earnings (PR Newswire)
21.12.22	Abbott : FreeStyle Libre 3 Integrated With Automated Insulin Delivery System Mylife Loop In Germany (RTTNews)
21.12.22	Abbott's FreeStyle Libre® 3 Integrated with Automated Insulin Delivery System mylife™ Loop in Germany (PR Newswire)
20.12.22	Abbott to Present at J.P. Morgan Healthcare Conference (PR Newswire)
19.12.22	Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain (PR Newswire)
13.12.22	Abbott and the Brain Injury Association of America launch Concussion Awareness Now coalition; team up with Rebel Wilson to raise awareness on seriousness of concussions (PR Newswire)
09.12.22	Abbott Increases Quarterly Dividend, Marking 51 Consecutive Years of Dividend Growth (PR Newswire)
17.11.22	Abbott Receives Three CES 2023 Innovation Awards for Advancements in Health Technology (PR Newswire)
31.10.22	ABT FINAL DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT (PR Newswire)
28.10.22	Abbott's FreeStyle Libre® is Named Best Medical Technology in Last 50 Years by the Galien Foundation (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Börse New York in Grün: So steht der NASDAQ 100 aktuell
20.12.24		SPI-Handel aktuell: SPI zum Handelsende leichter
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Handel in Europa: STOXX 50 schliesst im Minus

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Börse New York in Grün: So steht der NASDAQ 100 aktuell

20.12.24

SPI-Handel aktuell: SPI zum Handelsende leichter

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten